User profiles for Jean-Louis A. Parmasad

Jean-Louis A Parmasad

University of Ottawa
Verified email at uottawa.ca
Cited by 14

Constitutive nuclear accumulation of endogenous alpha-synuclein in mice causes motor impairment and cortical dysfunction, independent of protein aggregation

…, KM Ricke, K Horsthuis, JLA Parmasad… - Human Molecular …, 2022 - academic.oup.com
A growing body of evidence suggests that nuclear alpha-synuclein (αSyn) plays a role in
the pathogenesis of Parkinson’s disease (PD). However, this question has been difficult to …

[PDF][PDF] Characterizing the differential distribution and targets of Sumo1 and Sumo2 in the mouse brain

…, ZA Fisk, M Mitkovski, HM Geertsma, JLA Parmasad… - iScience, 2023 - cell.com
SUMOylation is an evolutionarily conserved eukaryotic posttranslational protein modification
with broad biological relevance. Differentiating between the major small ubiquitin-like …

[HTML][HTML] Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy

JLA Parmasad, KM Ricke, B Nguyen, MG Stykel… - Cell Death & …, 2024 - nature.com
Parkinson’s disease (PD) is a debilitating neurodegenerative disease characterized by the
loss of midbrain dopaminergic neurons (DaNs) and the abnormal accumulation of α-…

Genetic and pharmacological reduction of CDK14 mitigates α-synuclein pathology in human neurons and in rodent models of Parkinson's disease

JLA Parmasad, KM Ricke, MG Stykel, B Buchner-Duby… - bioRxiv, 2022 - biorxiv.org
Parkinsona’s disease (PD) is a debilitating neurodegenerative disease characterized by the
loss of midbrain dopaminergic neurons (DaNs) and the abnormal accumulation of α-…

Characterizing the differential distribution and targets of Sumo paralogs in the mouse brain

…, ZA Fisk, M Mitkovski, HM Geertsma, JLA Parmasad… - bioRxiv, 2022 - biorxiv.org
SUMOylation is an evolutionarily conserved and essential mechanism whereby Small
Ubiquitin Like Modifiers, or SUMO proteins (Sumo in mice), are covalently bound to protein …

Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy

MWC Rousseaux, JL Parmasad, K Ricke, M Stykel… - 2023 - researchsquare.com
Parkinson's disease (PD) is a debilitating neurodegenerative disease characterized by the
loss of midbrain dopaminergic neurons (DaNs) and the abnormal accumulation of α-…

Constitutive nuclear accumulation of endogenous alpha-synuclein in mice causes motor dysfunction and cortical atrophy, independent of protein aggregation

…, TR Suk, KM Ricke, K Horsthuis, JLA Parmasad… - bioRxiv, 2021 - biorxiv.org
Background A growing body of evidence suggests that nuclear alpha-synuclein (αSyn) plays
a role in the pathogenesis of Parkinson’s disease (PD). However, this question has been …

alpha-Synuclein pre-formed fibrils preparation and stereotactic injection into Mus Musculus brain

JL Parmasad - 2024 - slack.protocols.io
Preparation of seed-competent alpha-Synuclein pre-formed fibrils and subsequent
stereotactic injection into Mus Musculus brain as a model of synucleinopathy.

Young Researchers' Brain Health Research Day Joint ConferenceEffect of prior treatment history and sex on antidepressant response to subanesthetic ketamine …

A Farah, A Santos, A Roy, A Zahrai, BS Bono, B Hoffe… - 2019 - jpn.ca
Background Only 35% of patients with major depressive disorder remit after first-line
treatment on medications with antidepressant properties. Furthermore, sex differences in …

2020-2021 IgNITE Medical Case Competition: Regenerative Medicine

D Bojic, B Bezuidenhout, H Gill - … in Natural and Clinical Science and …, 2021 - urncst.com
The IgNITE Medical Case Competition is an annual research case competition organized
by students at the University of Ottawa. Our mission is to provide high school and university …